Top Story

Mild adrenal steroidogenic defects common in patients with high BP

December 26, 2014

Mild defects of adrenal steroidogenesis occur in nearly half of patients with high blood pressure, according to research published in the International Journal of Endocrinology.

In patients with either essential or secondary high BP, secretion of aldosterone is commonly dependent on adrenocorticotropic hormone (ACTH), according to researchers.

Difficulties in European orthopaedic care can stem from elevated obesity rates

December 26, 2014
The rates of obesity have tripled in European countries since the 1980s and this trend poses as one of the greatest public health challenges for the 21st century…
In the Journals

Insulin resistance, other factors associated with high ALT levels in NAFLD, NASH

December 26, 2014
In a prospective study, patients with nonalcoholic fatty liver disease and nonalcoholic steatosis who had high levels of alanine aminotransferase also had high levels of…
In the Journals

Metformin appears safe for patients with mild to moderate CKD

December 26, 2014
Clinicians may expand the use of metformin in patients with type 2 diabetes with mild to moderate kidney disease cautiously, based on literature showing limited evidence…
FDA News

FDA approves Saxenda injection therapy for weight management

December 26, 2014
The FDA granted approval to liraglutide 3-mg injection as the first once-daily human glucagon-like peptide-1 analogue to help manage obese or overweight patients…
More News Headlines »
low no

Low- and No-Calorie Sweeteners in Weight Management: What Do You Need to Know?

This activity is supported by an educational grant from the American Beverage Association.

The use of low- and no-calorie sweeteners continues to grow as consumers continue to purchase foods and beverages…
More »
Meeting News Coverage Video
thumbnail for video 3890508474001

Lenvatinib, sorafenib may significantly impact treatment of differentiated thyroid cancer

November 13, 2014
Marcia S. Brose, MD, PhD, associate professor at the University of Pennsylvania and director of the thyroid cancer…
More »
Screening and Treatment of Diabetes-Associated Eye Disease

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »